Accretion Nutraveda share news, announcements and annual reports
BSE: 544694Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹271.80.
28 Oct: open ₹290.00, high ₹290.00, low ₹290.00
- Next results date: the board meets on 31 Oct 2026 to consider: half yearly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹210 Cr2,550th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 41.43
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.92
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Feb 2026
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 14.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.12
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 13,000
Accretion Nutraveda has 36 announcements on record, routine notices left out; 5 in the 30 days to 28 Oct 2026, the latest on 26 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Accretion Nutraveda half-yearly results
The board meets on 31 Oct 2026 to consider half yearly results
Notice filed 26 Oct 2026
Accretion Nutraveda annual reports, presentations and earnings calls
The company's own documents, latest first.Accretion Nutraveda financials, year by year
Annual reports1
- Annual report, year to Mar 20264 Aug 2026
Accretion Nutraveda share news and announcements
Newest first.
Oct 2026
26 Oct · Board meeting
Meeting on 31 Oct 2026: half yearly results10 Oct · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
10 Oct · Meeting
Sep 2026
9 Sep · Meeting
2 Sep · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
1 Sep · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
1 Sep · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Aug 2026
6 Aug · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Jul 2026
May 2026
4 May · Board meeting
Meeting on 8 May 2026: audited results
Apr 2026
29 Apr · Legal
Exchange has sought clarification from Accretion Nutraveda Ltd on April 29, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....1 Apr · Intimation For Change Of Corporate Identification Number (CIN) Of The Company.
Mar 2026
26 Mar · Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
26 Mar · Board meeting
Feb 2026
19 Feb · Legal
Exchange has sought clarification from Accretion Nutraveda Ltd on February 19, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....4 Feb · Listing of Equity Shares of Accretion Nutraveda Ltd
Trading Members of the Exchange are hereby informed that effective from February 04, 2026, the Equity Shares of Accretion Nutraveda Ltd (Scrip Code: 544694) are listed and admitted to dealings ....
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 11 May 2026Board or managers changedup 2.12%+3.5 pts vs Nifty 500market median 0.0% · five sessions −8.1% (−5.3 pts vs Nifty 500) · volume 0.5× usual · The announcement